Treatment of intracranial branch atheromatous disease
10.3760/cma.j.issn.1673-4165.2016.08.013
- VernacularTitle:颅内分支动脉粥样硬化病变的治疗
- Author:
Xiangxiang PENG
;
Zhiming ZHOU
- Publication Type:Journal Article
- Keywords:
Stroke;
Brain Ischemia;
Intracranial Arteriosclerosis;
Platelet Aggregation Inhibitors;
Anticoagulants;
Thrombolytic Therapy;
Neuroprotective Agents;
Drug Therapy,Combination;
Risk Factors
- From:
International Journal of Cerebrovascular Diseases
2016;24(8):756-758,759
- CountryChina
- Language:Chinese
-
Abstract:
Branch atheromatous disease (BAD) is a deep cerebral infarction at the entrance or the origin of perforating artery because of atherosclerosis causing lumen stenosis or occlusion. It is common in clinical practice and there is often a clinical feature of progression or fluctuation in the acute phase. Its prognosis is poor and it will bring a heavy burden to the family and society. Therefore, the early intervention for patients with BAD is very important. This article reviews the treatment of BAD.
